GLP-1 Drug Shortages

Resolved: 2024-12-19 · All dose strengths resolved late 2024. Pharmacy fills generally available.

What this means for patients

The 2025 resolution of GLP-1 shortages means brand-name medications (Wegovy, Zepbound, Mounjaro, Ozempic) are generally available at most pharmacies. Compounded GLP-1 production legal basis narrowed post-resolution — patients on compounded products may face increasing pressure to switch to FDA-approved alternatives as the regulatory environment tightens.

For patients who've been managing their treatment around shortages: this is the right time to discuss longer-term planning with your prescriber, especially if you've been bouncing between formulations or pharmacies.

If shortages return

Sign up for our monthly newsletter for FDA shortage status updates. Or opt into price-drop alerts on specific drugs — same subscriber record covers both.

Sources

• FDA Drug Shortage Database
• FDA Drug Shortages program page
• Manufacturer-issued supply communications (Novo Nordisk, Eli Lilly)

Status reviewed manually against FDA Drug Shortage Database. Information current as of 2026-06-02. Pharmacy-level availability may differ from FDA-status from distribution timing. Always confirm with your pharmacy before assuming availability. Full disclaimer.